- Home
- ESE vs TMDX Comparison
ESE vs TMDX Comparison
Compare ESE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESE
- TMDX
- Stock Information
- Founded
- ESE 1990
- TMDX 1998
- Country
- ESE United States
- TMDX United States
- Employees
- ESE N/A
- TMDX N/A
- Industry
- ESE Telecommunications Equipment
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ESE Telecommunications
- TMDX Health Care
- Exchange
- ESE Nasdaq
- TMDX Nasdaq
- Market Cap
- ESE 4.9B
- TMDX 4.8B
- IPO Year
- ESE N/A
- TMDX 2019
- Fundamental
- Price
- ESE $191.38
- TMDX $115.68
- Analyst Decision
- ESE Strong Buy
- TMDX Buy
- Analyst Count
- ESE 2
- TMDX 9
- Target Price
- ESE $187.50
- TMDX $129.88
- AVG Volume (30 Days)
- ESE 220.0K
- TMDX 909.2K
- Earning Date
- ESE 08-06-2025
- TMDX 07-30-2025
- Dividend Yield
- ESE 0.17%
- TMDX N/A
- EPS Growth
- ESE 19.62
- TMDX N/A
- EPS
- ESE 4.56
- TMDX 1.41
- Revenue
- ESE $1,071,861,000.00
- TMDX $488,227,000.00
- Revenue This Year
- ESE $17.26
- TMDX $34.07
- Revenue Next Year
- ESE $14.04
- TMDX $20.76
- P/E Ratio
- ESE $42.23
- TMDX $82.00
- Revenue Growth
- ESE 8.40
- TMDX 64.43
- 52 Week Low
- ESE $108.70
- TMDX $55.00
- 52 Week High
- ESE $196.13
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- ESE 56.11
- TMDX 38.66
- Support Level
- ESE $184.54
- TMDX $109.59
- Resistance Level
- ESE $194.65
- TMDX $127.97
- Average True Range (ATR)
- ESE 4.08
- TMDX 5.57
- MACD
- ESE -0.47
- TMDX -2.35
- Stochastic Oscillator
- ESE 59.02
- TMDX 22.52
About ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace and Defense, Utility Solutions Group (USG), and Test. The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.